Liqing He, Vatsalya Vatsalya, Xipeng Ma, Jiayang Zhang, Xinmin Yin, Seongho Kim, Wenke Feng, Craig J. McClain, Xiang Zhang – 19 January 2021 – Bile acids (BAs) play important functions in the development of alcohol‐associated liver disease (ALD). In the current study, urine BA concentrations in 38 patients with well‐described alcohol‐associated hepatitis (AH) as characterized by Model for End‐Stage Liver Disease (MELD), 8 patients with alcohol‐use disorder (AUD), and 19 healthy controls (HCs) were analyzed using liquid chromatography–mass spectrometry.

Yi Luo, Samir Wadhawan, Alex Greenfield, Benjamin E. Decato, Abdul M. Oseini, Rebecca Collen, Diane E. Shevell, John Thompson, Gabor Jarai, Edgar D. Charles, Arun J. Sanyal – 19 January 2021 – Nonalcoholic steatohepatitis (NASH) is a major cause of liver‐related morbidity and mortality worldwide. Liver fibrosis stage, a key component of NASH, has been linked to the risk of mortality and liver‐related clinical outcomes.

Cynthia Levy, Shahnaz Sultan – 18 January 2021

Arata Itoh, David Adams, Wenting Huang, Yuehong Wu, Kritika Kachapati, Kyle J. Bednar, Patrick S. C. Leung, Weici Zhang, Richard A. Flavell, M. Eric Gershwin, William M. Ridgway – 18 January 2021

Yisheng He, Mai Shi, Xu Wu, Jiang Ma, Kevin Tak‐Pan Ng, Qingsu Xia, Lin Zhu, Peter Pi‐Cheng Fu, Kwan Man, Stephen Kwok‐Wing Tsui, Ge Lin – 18 January 2021

James Richards, Alex Gimson, Yexin Joh, Christopher J.E. Watson, James Neuberger – 18 January 2021 – During the past 5 decades, liver transplantation has moved from its pioneering days where success was measured in days to a point where it is viewed as a routine part of medical care. Despite this progress, there are still significant unmet needs and outstanding questions that need addressing in clinical trials to improve outcomes for patients.

Durairaj Sekar, Auxzilia Preethi. K – 17 January 2021

Lingzhen Jin, Xiaofei Li – 17 January 2021

Julie K. Heimbach, James F. Trotter, James Pomposelli, Matt Cafarella, Samantha M. Noreen – 17 January 2021

Kara Wegermann, Melanie E. Garrett, Jiayin Zheng, Andrea Coviello, Cynthia A. Moylan, Manal F. Abdelmalek, Shein‐Chung Chow, Cynthia D. Guy, Anna Mae Diehl, Allison Ashley‐Koch, Ayako Suzuki – 17 January 2021 – The development of fibrosis in nonalcoholic fatty liver disease (NAFLD) is influenced by genetics, sex, and menopausal status, but whether genetic susceptibility to fibrosis is influenced by sex and reproductive status is unclear.